Bristol-Myers Squibb Co. (BMY) Misses Q3 EPS by 1c; Sees EPS at High End
Tweet Send to a Friend
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q3 EPS of $0.41, $0.01 worse than the analyst estimate of $0.42 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
